Apple News Facebook Twitter 新浪微博 Instagram YouTube Tuesday, Feb 9, 2021

CanSinoBIO's COVID-19 vaccine 74.8% effective in Pakistan trials

(CGTN)    09:59, February 09, 2021

China's CanSino Biologics Inc.'s (CanSinoBIO) COVID-19 vaccine showed 74.8 percent efficacy in preventing symptomatic cases and a 100-percent success rate in stopping severe disease among Pakistanis in Phase III clinical trials, Special Assistant to the Prime Minister on Health Dr. Faisal Sultan said on Monday.

(For the latest China news, Please follow People's Daily on Twitter and Facebook)(Web editor: Meng Bin, Liang Jun)

Add your comment

Related reading

We Recommend

Most Read

Key Words